Cargando…
Ribosome-Directed Therapies in Cancer
The human ribosomes are the cellular machines that participate in protein synthesis, which is deeply affected during cancer transformation by different oncoproteins and is shown to provide cancer cell proliferation and therefore biomass. Cancer diseases are associated with an increase in ribosome bi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495564/ https://www.ncbi.nlm.nih.gov/pubmed/36140189 http://dx.doi.org/10.3390/biomedicines10092088 |
_version_ | 1784794049260027904 |
---|---|
author | Temaj, Gazmend Chichiarelli, Silvia Eufemi, Margherita Altieri, Fabio Hadziselimovic, Rifat Farooqi, Ammad Ahmad Yaylim, Ilhan Saso, Luciano |
author_facet | Temaj, Gazmend Chichiarelli, Silvia Eufemi, Margherita Altieri, Fabio Hadziselimovic, Rifat Farooqi, Ammad Ahmad Yaylim, Ilhan Saso, Luciano |
author_sort | Temaj, Gazmend |
collection | PubMed |
description | The human ribosomes are the cellular machines that participate in protein synthesis, which is deeply affected during cancer transformation by different oncoproteins and is shown to provide cancer cell proliferation and therefore biomass. Cancer diseases are associated with an increase in ribosome biogenesis and mutation of ribosomal proteins. The ribosome represents an attractive anti-cancer therapy target and several strategies are used to identify specific drugs. Here we review the role of different drugs that may decrease ribosome biogenesis and cancer cell proliferation. |
format | Online Article Text |
id | pubmed-9495564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94955642022-09-23 Ribosome-Directed Therapies in Cancer Temaj, Gazmend Chichiarelli, Silvia Eufemi, Margherita Altieri, Fabio Hadziselimovic, Rifat Farooqi, Ammad Ahmad Yaylim, Ilhan Saso, Luciano Biomedicines Review The human ribosomes are the cellular machines that participate in protein synthesis, which is deeply affected during cancer transformation by different oncoproteins and is shown to provide cancer cell proliferation and therefore biomass. Cancer diseases are associated with an increase in ribosome biogenesis and mutation of ribosomal proteins. The ribosome represents an attractive anti-cancer therapy target and several strategies are used to identify specific drugs. Here we review the role of different drugs that may decrease ribosome biogenesis and cancer cell proliferation. MDPI 2022-08-26 /pmc/articles/PMC9495564/ /pubmed/36140189 http://dx.doi.org/10.3390/biomedicines10092088 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Temaj, Gazmend Chichiarelli, Silvia Eufemi, Margherita Altieri, Fabio Hadziselimovic, Rifat Farooqi, Ammad Ahmad Yaylim, Ilhan Saso, Luciano Ribosome-Directed Therapies in Cancer |
title | Ribosome-Directed Therapies in Cancer |
title_full | Ribosome-Directed Therapies in Cancer |
title_fullStr | Ribosome-Directed Therapies in Cancer |
title_full_unstemmed | Ribosome-Directed Therapies in Cancer |
title_short | Ribosome-Directed Therapies in Cancer |
title_sort | ribosome-directed therapies in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495564/ https://www.ncbi.nlm.nih.gov/pubmed/36140189 http://dx.doi.org/10.3390/biomedicines10092088 |
work_keys_str_mv | AT temajgazmend ribosomedirectedtherapiesincancer AT chichiarellisilvia ribosomedirectedtherapiesincancer AT eufemimargherita ribosomedirectedtherapiesincancer AT altierifabio ribosomedirectedtherapiesincancer AT hadziselimovicrifat ribosomedirectedtherapiesincancer AT farooqiammadahmad ribosomedirectedtherapiesincancer AT yaylimilhan ribosomedirectedtherapiesincancer AT sasoluciano ribosomedirectedtherapiesincancer |